Markets › India › NSE › BMLL

Bio Medica Laboratories Ltd

NSE:BMLLHealth Technology

₹155.50−5.47%At closeAt close · Mon 19 Oct · ≈ AED 6.01 · Market cap —

Ratio	FY2022	FY2022	FY2023	FY2024	FY2025	YoY
Gross margin	12.2%	12.2%	34.1%	40.3%	49.6%	+9.3 pts
Operating margin	—	7.4%	29.7%	37.2%	42.9%	+5.7 pts
Net margin	2.1%	2.1%	16.4%	25.6%	27.3%	+1.7 pts
EBITDA margin	10.5%	10.5%	36.9%	39.8%	45.6%	+5.8 pts
Return on equity	—	13.7%	50.6%	66.5%	44.4%	−22.1 pts
Return on assets	1.9%	1.9%	12.8%	25.0%	16.1%	−9.0 pts
Return on capital employed	—	16.3%	34.8%	64.2%	34.2%	−30.1 pts
Debt / equity	—	3.9×	2.1×	1.0×	1.5×	+48.0%
Debt / assets	54.7%	54.7%	53.7%	38.4%	54.5%	+16.2 pts
Interest coverage	0.0×	1.6×	4.7×	11.9×	8.2×	−31.1%
Current ratio	—	0.9×	1.6×	1.8×	2.8×	+55.8%
Quick ratio	—	0.5×	0.5×	0.3×	1.0×	+195.2%
Cash ratio	—	0.0×	0.0×	0.0×	0.0×	+1248.5%
Asset turnover	0.9×	0.9×	0.8×	1.0×	0.6×	−39.8%
Inventory turnover	—	3.4×	1.3×	0.9×	0.6×	−33.0%
Receivables turnover	—	4.0×	6.5×	9.3×	4.0×	−57.4%
Dividend payout	—	0.0%	0.0%	0.0%	—	—